High-Dose CBD for Neuropathic Pain: New RCT Explained
A new randomized, double-blind, placebo-controlled trial found high-dose CBD reduced neuropathic pain after spinal cord injury by about 14% versus 6.5% for placebo. Dr. Caplan reviews the evidence, the study's real limitations, and what it does and does…
Cannabis-Tobacco Co-Use Cognition Impact – July 2026 Review
This July 2026 review covers cannabis-tobacco co-use cognition and its clinical implications. Multiple cannabis compounds influence glucose metabolism. The digest highlights key findings on cannabis-tobacco interactions and cognition.
Nebraska Approves Permanent Medical Marijuana Regulations: What Patients Should Watch Next
Nebraska medical marijuana regulations were approved permanently on July 1, 2026. Patients should watch for how these regulations affect access and legal challenges. The new framework marks a milestone but practical usability remains uncertain.
CED Cannabis Science Digest: Legalization, Mood, and Pain Signals
This digest highlights the Luxembourg cannabis legalization study alongside two preclinical CBD signals on mood and neuropathic pain. These findings are informative but not treatment proof. They help clarify policy monitoring and translational research…
Illinois SB 3222: What the New Hemp Safety Law Means for Medical Cannabis Patients
Illinois hemp safety law SB 3222 restricts intoxicating hemp sales to those under 21 and expands medical cannabis access through telehealth and curbside pickup. The law aims to improve patient safety and streamline access. However, real-world…
THC/CBD for Restless Legs Syndrome: What a Small Trial Shows
A July 2, 2026 clinical trial found lower restless legs syndrome scores and less wake-after-sleep-onset with a low-dose THC/CBD product. The signal is interesting, but the 18-patient open-label design and MS-heavy cohort leave major caveats. Here is what…
CED Cannabis Science Digest: 3 Road Safety, Edible Toxicity, and Pain Biomarker Signals
This digest presents cannabis road safety signals, edible toxicity insights, and pain biomarker findings. Each signal offers valuable information for clinicians and patients. Understanding these signals is crucial for informed discussions about cannabis…
Cannabis Science Evidence Report: Pediatric Coma, Cannabinoid Ingestion, and Urine Toxicology Screening
This report discusses pediatric cannabinoid ingestion screening. It highlights the importance of rapid urine screening in cases of pediatric coma. The findings emphasize the need for cautious interpretation of results.
Cannabis and Working Memory: Brain Imaging Study Explains Cognitive Impact
The 2026 cannabis working memory study highlights significant findings on cognitive effects. It shows how cannabis use correlates with reduced brain activity in working memory tasks. Understanding these implications is crucial for patient counseling and…
CED Cannabis Science Digest: 3 Behavior, CBD, and Formulation Signals Worth Watching
Today's standalone pediatric safety report captured the strongest signal from the scan. This digest preserves three additional verified lower-certainty papers worth watching: a Bangkok mixed-method study on cannabis and sexual-health behavior context, a…
